Credit: Getty Images. Avacopan plus rituximab offers a superior remission rate at 52 weeks and lower risk of relapse compared with prednisone taper plus rituximab, with a similar safety profile.

In a single-center, single-arm, open-label pilot study, 30 adults (mean age, 73.7 years) with GCA received 162 mg of tocilizumab as a subcutaneous injection once a week for 52 weeks, plus prednisone ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...

A combination of tocilizumab plus prednisone-tapered therapy was superior to placebo plus steroid taper for achieving glucocorticoid-free remission in giant-cell arteritis (GCA), the phase 3 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. To compare avacopan (CCX168, ChemoCentryx) with a ...

"There is something new in giant cell arteritis at last, and the era of unending glucocorticoid treatment with no viable alternative is over," said John H. Stone, MD, PhD, of Harvard Medical School, ...

Please provide your email address to receive an email when new articles are posted on . Tocilizumab plus prednisone was linked to a sixfold reduced risk for treatment failure in patients with giant ...

Credit: Getty images. Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion ...

I’d become an eating machine with a loathsome attitude on prednisone, so I decided to conduct my own taper of the drug. Four months after my allogeneic bone marrow transplant, I left the Stanford ...